Skip to content

A study comparing two treatments to reduce long-term knee pain in arthritis patients nerve blockade by ablation vs steroid injection using ultrasound guidance

Comparative study to assess the analgesic efficacy of Cooled Radio Frequency Ablation of genicular nerve and Intra Articular CorticoSteroids, under ultrasound guidance for chronic knee pain from Osteoarthritis knee. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092943
Enrollment
40
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Radio frequency ablation: Cooled radio frequency ablation of genicular nerves to treat OA knee pain Control Intervention1: Intra articular steroids: Intra articular corticosteroids to t

Sponsors

ESI medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with ACOR criteria with radiological evidence but not willing for surgery

Exclusion criteria

Exclusion criteria: Patient refusal, bleeding diathesis, previous Intra articular injection in last 3 months, previous knee surgeries, rheumatoid arthritis, ligament injuries

Design outcomes

Primary

MeasureTime frame
To compare analgesic efficacy of cooled RFA of genicular nerve and Intra articular cortico steroids under ultrasound guidance for chronic knee pain in OA kneeTimepoint: Time point of pain assessment pre procedure, immediately after procedure, 24 hrs, 1 week, 2 week and 4 week interval

Secondary

MeasureTime frame
To assess improvement of knee functionTimepoint: Assessed using WOMAC score

Countries

India

Contacts

Public ContactV Vaishnavi
vaishu.8492@gmail.com9789993988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026